FindTrial
Sign In

Study of the role of hyperimmunity in half-headache

Investigation of Autoimmunity in migraine patients: A perspective case-controlled study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2022/08/044685
Enrollment
50
Registered
2022-08-05
Start date
Unknown
Completion date
Unknown
Last updated
2025-09-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: G894- Chronic pain syndrome

Interventions

Control Intervention1: NIL: NIL

Sponsors

Sri Ramachandra Institute of Higher Education and Research DU
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Migraine with aura and without aura patients 2. Patients between 18 to 60 years old 3. Patients affected by COVID-19 4. Patients with other autoimmune disorder

Exclusion criteria

Exclusion criteria: 1. Migraine patients with other comorbid diseases 2. Patients who had not taken any medications for migraine 3. Pregnant and lactating women

Design outcomes

Primary

MeasureTime frame
This study will compare the levels of autoantibodies in migraine patients with those of healthy volunteers in order to determine whether immunological malfunction may be the cause of migraine attacks.Timepoint: Investigation of 6 months—

Secondary

MeasureTime frame
This study will detect the autoantibody levels in migraine patients and will help in better understanding of migraine as an autoimmune disorderTimepoint: Investigation of 1 year—

Countries

India

Contacts

Public ContactPavithra M

Sri Ramachandra Faculty of Pharmacy Sri Ramachandra Institute of Higher Education and Research

murugesan.a@sriramachandra.edu.in8870151588

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026